Clinical Trial Update: A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating HRS-6213 in healthy subjects and patients with solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumor

Drugs mentioned

• HRS-6213

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Patients With Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING